Author： Nguewa Paul A Calvo Alfonso Pullamsetti Soni Savai Banat Gamal Andre Grimminger Friedrich Savai Rajkumar
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.1, 2011-01, pp. : 61-74
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. :
Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets, Vol. 17, Iss. 6, 2016-05 ,pp. :
Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer
By Fasano Morena Della Corte Carminia Maria Califano Raffaele Capuano Annalisa Troiani Teresa Martinelli Erika Ciardiello Fortunato Morgillo Floriana
Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. :
Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. :